CELZ - CIK 0001187953
The table below shows CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$5.86M | -$5.30M | -$8.03M | -$7.80M | -$2.22M | -$434.56K |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$50.50K | $6.32M | $3.45M | -$10.08M | $0.00 | -$250.00K |
| Dividends paid | - | - | - | - | - | - |
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. reported operating cash flow of -$5.86M for fiscal year 2025. That is down 10.5% from -$5.30M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$445.23K (FY 2016) to -$5.86M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $10.00K | $174.96K | $270.95K | $0.00 | - | - |
| Financing cash flow | $7.17M | $1.45M | -$270.95K | $15.47M | $12.84M | $693.92K |